| Serial Number | 98117779 |
| Word Mark | JUNEVITY |
| Filing Date | Friday, August 4, 2023 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Wednesday, May 22, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Pharmaceutical preparations for the treatment and prevention of human diseases and disorders; pharmaceutical preparations for the treatment of physiological diseases; pharmaceutical products for cell therapy to treat human diseases, disorders, and aging; cell therapy products, namely, pharmaceutical preparations for cell therapy to treat human aging, diseases, and disorders; pharmaceutical preparations for gene therapy to treat human diseases and disorders; gene therapy preparations to treat human diseases and disorders; chemical preparations for pharmaceutical or medical purposes, namely, for gene and cell therapy |
| Goods and Services | Medical and scientific research and development; medical and scientific research and development in connection with cell aging and restoration; research and development of new products in the pharmaceutical and biotechnology fields; research and development of new technology in the field of gene therapy, genome writing, and genome engineering; scientific testing, inspection, research, and development of pharmaceutical preparations for gene therapy; scientific testing, inspection, research, and development of enzyme preparations for gene and cell therapy; genomic analysis and sequencing services for scientific, medical, and research purposes; medical and scientific research in the fields of genomics; providing medical and scientific research information in the fields of genomics; medical and scientific research for the purpose of elevating single cell genome variants for the purpose of identifying transcription factors; research, development and scientific consultancy in the field of genomics; medical research, namely, compiling data for research purposes in the field of genomics; providing medical research information in the field of genomics in relation to disease treatment and aging; providing on-line non-downloadable software for collecting, analyzing, reporting, and tracking data and information in the field of genomics; platform as a service (PAAS) featuring computer software platforms for collecting, analyzing, reporting, and tracking data and information in the field of genomics; software as a service (SAAS) services featuring software for collecting, analyzing, reporting, and tracking data and information in the field of genomics; providing temporary use of non-downloadable computer software incorporating machine learning (ML) and artificial intelligence (AI) technology for genomic analysis and sequencing for scientific, medical, and research purposes; providing temporary use of non-downloadable computer software incorporating machine learning (ML) and artificial intelligence (AI) technology for medical and scientific research in the field of genomics; providing temporary use of non-downloadable computer software for providing medical and scientific research information in the field of genomics; providing temporary use of non-downloadable computer software for medical and scientific research in connection with detecting variants in cells to treat disease and mitigate aging; providing temporary use of non-downloadable computer software for research, development and consultancy in the field of genomics; providing temporary use of non-downloadable computer software for compiling data for research purposes in the field of genomics; providing temporary use of non-downloadable computer software for providing medical research information in the field of genomics; providing temporary use of non-downloadable computer software for medical testing, diagnosis, and treatment; providing temporary use of non-downloadable computer software for medical analysis and diagnosis in the field of genomics for the purpose of disease treatment; providing temporary use of non-downloadable computer software for medical analysis and diagnosis in the field of genomics; providing temporary use of non-downloadable computer software for medical and scientific research in connection with aging |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, September 3, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, September 3, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Junevity, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Mateo, CA 94401 |
| Event Date | Event Description |
| Tuesday, August 8, 2023 | NEW APPLICATION ENTERED |
| Sunday, September 3, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, April 5, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, May 22, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, May 22, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, May 22, 2024 | NON-FINAL ACTION E-MAILED |